Last reviewed · How we verify
Satraplatin in combo with vinorelbine — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Satraplatin in combo with vinorelbine (Satraplatin in combo with vinorelbine) — Southern Europe New Drug Organization.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Satraplatin in combo with vinorelbine TARGET | Satraplatin in combo with vinorelbine | Southern Europe New Drug Organization | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Satraplatin in combo with vinorelbine CI watch — RSS
- Satraplatin in combo with vinorelbine CI watch — Atom
- Satraplatin in combo with vinorelbine CI watch — JSON
- Satraplatin in combo with vinorelbine alone — RSS
Cite this brief
Drug Landscape (2026). Satraplatin in combo with vinorelbine — Competitive Intelligence Brief. https://druglandscape.com/ci/satraplatin-in-combo-with-vinorelbine. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab